{
  "url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/regulation-16",
  "json_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025/regulation-16.json",
  "legislation": "uksi/2025/749",
  "legislation_title": "The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2025",
  "legislation_url": "https://openlegislation.uk/medical-devices-and-blood-safety-and-quality-fees-amendment-regulations-2025",
  "path": "regulation/16",
  "kind": "regulation",
  "number": "16",
  "heading": "Amendment of regulation 16",
  "text": "After regulation 16(4) (clinical investigation fees), insert—\n“(4A) Where the relevant fee is payable pursuant to paragraph (1)(a) by a small company, if the small company so requests to the Secretary of State in writing, 50% of that fee shall be payable when the application to which it relates is submitted to the Secretary of State and 50% of that fee shall be payable within six months of the date on which the application was submitted.\n(4B) For the purpose of this regulation, a company is a small company if, for the financial year before that in which the application or notification is submitted or given, the total value of products it has sold or supplied for the financial year is not more than the amount specified in item 1 in section 382(3) (qualification of company as small) of the Companies Act 2006 and either—\n(a) the company’s balance sheet total as defined in section 382(5) of the Companies Act 2006 is not more than the amount specified in item 2 in section 382(3) of that Act; or\n(b) the average number of persons employed by the company in the financial year before that in which the application or notice is submitted or given (determined on a weekly basis) does not exceed the number specified in item 3 in section 382(3) of that Act.\n(4C) In this regulation, a reference to section 382 of the Companies Act 2006 is a reference to that section as amended by the Companies (Accounts and Reports) (Amendment and Transitional Provision) Regulations 2024.”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Amended by S.I. 2023/377."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "2006 c. 46. A relevant amendment was made by S.I. 2015/980."
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "S.I. 2024/1303."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2025/749/regulation/16",
    "retrieved_at": "2026-10-28T21:14:21.127792+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}